Cg. Thornton et al., NOVEL METHOD FOR PROCESSING RESPIRATORY SPECIMENS FOR DETECTION OF MYCOBACTERIA BY USING C-18-CARBOXYPROPYLBETAINE - BLINDED STUDY, Journal of clinical microbiology, 36(7), 1998, pp. 1996-2003
A novel method for processing respiratory specimens to improve culture
and acid-fast staining of mycobacteria is introduced. This new method
utilized methyl-N-(n-octadecyl)-N-(3-carboxypropyl)ammonium inner sal
t (Chemical Abstract Service no. 78195-27-4), also known as C-18-carbo
xyropylbetaine (CB-18). In a blinded, five-center study, CB-18-based p
rocessing was compared to the standard method combining NALC and NaOH
(NALC/NaOH). A total of 573 respiratory specimens were tested. Individ
ual specimens were split approximately equally; the host institutions
processed half of each specimen by the NALC/NaOH method, while the oth
er half was processed with CB-18 at Quest Diagnostics-Baltimore. A tot
al of 106 specimens were culture positive for acid-fast bacilli (AFB).
Replacement of the primary decontamination agent with CB-18 caused ch
anges in all diagnostic parameters. Aggregate culture sensitivity impr
oved by approximately 43% (P < 0.01), and smear sensitivity improved b
y approximately 58% (P < 0.01). The sensitivity of smear relative to t
hat of M. tuberculosis isolates exceeded 93% (P < 0.01) when specimens
were processed with CB-18. The average times to a positive result wer
e reduced by 7.3 days in liquid culture (P < 0.01) and 5.3 days on sol
id media (P < 0.05); however, the CB-18 method had a 20.8% contaminati
on rate in liquid culture versus a rate of approximately 7.5% with NAL
C/NaOH processing. There were also unusual reductions in liquid cultur
e sensitivity and smear specificity among CB-18-processed specimens. T
he characteristics of the latter parameters suggested that refinement
of the CB-18 processing method should allow further improvements in cu
lture sensitivity. This study showed that the CB-18 method has the pot
ential to improve both smear and culture detection for these important
human pathogens.